iKang Healthcare Group, Inc. (CIK: 0001524190) EDGAR, Information, Filings... CompaniesBIO.Com

iKang Healthcare Group, Inc.

Mailing address
B-6F, SHIMAO TOWER, 92A JIANGUO ROAD, CHAOYANG DISTRICT, Beijing, F4, 100022
Phone
86 10-5320-6688
State location
China
State of incorporation
N/A
Fiscal year end
March 31
SIC
8011 - (CF Office: Office of Life Sciences) SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Filings
N/A

iKang Healthcare Group, Inc. (CIK: 0001524190) is an American company incorporated in the state of China. Head office is located at B-6F, SHIMAO TOWER, 92A JIANGUO ROAD, CHAOYANG DISTRICT, Beijing, China, 100022. Work in the industry 8011 - (CF Office: Office of Life Sciences) SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE. iKang Healthcare Group, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

iKang Guobin Healthcare Group, Inc. from 2013-04-Dec to 2014-14-Feb

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by iKang Healthcare Group, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001140361-19-003349 (34 Act) Size: KB	Feb-15-2019	005-88530 19610650
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001140361-19-003134 (34 Act) Size: KB	Feb-14-2019	005-88530 19603498
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001104659-19-004637 (34 Act) Size: KB	Jan-31-2019	001-36403 19553857
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-19-003059 (34 Act) Size: KB	Jan-24-2019	005-88530 19538586
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-19-002855 (34 Act) Size: KB	Jan-23-2019	005-88530 19536588
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-19-002518 (33 Act) Size: KB	Jan-18-2019	333-202544 19533786
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-19-002517 (33 Act) Size: KB	Jan-18-2019	333-197289 19533785
SC 13E3/A	Document	Amendment to Schedule filed to report going private transactions Acc-no: 0001047469-19-000175 (34 Act) Size: KB	Jan-18-2019	005-88530 19533775
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-19-002516 (34 Act) Size: KB	Jan-18-2019	001-36403 19533760
25-NSE	Document	Acc-no: 0001354457-19-000030 (34 Act) Size: KB	Jan-18-2019	333-194263 19533285
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-18-074182 (34 Act) Size: KB	Dec-21-2018	001-36403 181247493
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-18-073429 (34 Act) Size: KB	Dec-18-2018	005-88530 181239334
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-18-073421 (34 Act) Size: KB	Dec-18-2018	005-88530 181239317
SC 13E3/A	Document	Amendment to Schedule filed to report going private transactions Acc-no: 0001047469-18-007656 (34 Act) Size: KB	Dec-14-2018	005-88530 181234521
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-18-072944 (34 Act) Size: KB	Dec-14-2018	001-36403 181234507
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-18-070440 (34 Act) Size: KB	Nov-29-2018	001-36403 181206964
8-A12B/A	Document	Amendment to Form for the registration / listing of a class of securities on a national securities exchange pursuant to section 12(b) Acc-no: 0001104659-18-070437 (34 Act) Size: KB	Nov-29-2018	001-36403 181206962
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-18-065273 (34 Act) Size: KB	Nov-01-2018	001-36403 181152058
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000769993-18-000514 (34 Act) Size: KB	Oct-30-2018	005-88530 181145952
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-18-059210 (34 Act) Size: KB	Sep-28-2018	001-36403 181092483

Recent 20 filings. View all iKang Healthcare Group, Inc. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

iKang Healthcare Group, Inc. overview
iKang Healthcare Group, Inc. job
iKang Healthcare Group, Inc. stock
iKang Healthcare Group, Inc. ownership
iKang Healthcare Group, Inc. CEO
iKang Healthcare Group, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.